Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Clinical trial NCT01010945 · COMPLETED

Trial details

NCT number: NCT01010945
Sponsor: OSI Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer

Start date: 2010-02-03
Primary completion: 2012-01-25
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.